Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Renalytix plc

Commencement of trading on OTCQB in the United States
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Announces Financing with Expected Size of up to $4 Million
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Reports Full Year Fiscal 2023 Results
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Announces Middle East Distribution Agreement with Vector Pharma
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
New Published Real-World Evidence Shows KidneyIntelX™ Utility
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Renalytix plc
Via GlobeNewswire
Tickers RNLX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.